Information about Ace and Tate Co-Investment Fund III
My details
*
*
*

Ace and Tate Co-Investment Fund III (SRL)

Company information

Status
Active

KVK number

78079772

VAT Number

Established
19-05-2020
Last balance sheet year
2023
Company size
Small 0 FTE
RSIN number
861257431
Principal activity
Activiteiten van financiële holdings
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Ace and Tate Co-Investment Fund III

2023 2022 2021 2020
Equity 524.440 0 % 524.440 0 % 524.440 0 % 524.440
Employees 0 0 0 0

Frequently asked questions

What is the KVK number of Ace and Tate Co-Investment Fund III?
The KVK number of Ace and Tate Co-Investment Fund III is 78079772
What is the VAT number of Ace and Tate Co-Investment Fund III?
Log in or start a free trial to view the VAT number.
Wat is the PEPPOL ID of Ace and Tate Co-Investment Fund III?
There is no information available about the PEPPOL ID of Ace and Tate Co-Investment Fund III or the company is not yet registered on the PEPPOL network.
When was Ace and Tate Co-Investment Fund III founded?
Ace and Tate Co-Investment Fund III was founded on 19-05-2020.
What is the address of Ace and Tate Co-Investment Fund III?
The current registered office of Ace and Tate Co-Investment Fund III is located at Emmaplein 4, 9711 AP Groningen.
When was the last time Ace and Tate Co-Investment Fund III filed their annual financial statements?
The most recent financial statements of Ace and Tate Co-Investment Fund III were filed on 31-12-2023.
How many employees does Ace and Tate Co-Investment Fund III have?
There are currently no employees working at Ace and Tate Co-Investment Fund III or no workforce information is available.
What is the annual turnover of Ace and Tate Co-Investment Fund III?
There is no turnover available for Ace and Tate Co-Investment Fund III.